Found: 2
Select item for more details and to access through your institution.
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 713, p. 1, doi. 10.1126/scitranslmed.adf4100
- By:
- Publication type:
- Article
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 642, p. 1, doi. 10.1126/scitranslmed.abn9243
- By:
- Publication type:
- Article